...
首页> 外文期刊>American Journal of Cancer Research >The G-protein coupled chemoattractant receptor FPR2 promotes malignant phenotype of human colon cancer cells
【24h】

The G-protein coupled chemoattractant receptor FPR2 promotes malignant phenotype of human colon cancer cells

机译:G蛋白偶联趋化因子受体FPR2促进人结肠癌细胞的恶性表型

获取原文
   

获取外文期刊封面封底 >>

       

摘要

The G-protein coupled chemoattractant receptor formylpeptide receptor-2 (FPR2 in human, Fpr2 in mice) is expressed by mouse colon epithelial cells and plays a critical role in mediating mucosal homeostasis and inflammatory responses. However, the biological role of FPR2 in human colon is unclear. Our investigation revealed that a considerable number of human colon cancer cell lines expressed FPR2 and its ligands promoted cell migration and proliferation. Human colon cancer cell lines expressing high levels of FPR2 also formed more rapidly growing tumors in immunocompromised mice as compared with cell lines expressing lower levels of FPR2. Knocking down of FPR2 from colon cancer cell lines highly expressing FPR2 reduced their tumorigenicity. Clinically, FPR2 is more highly expressed in progressive colon cancer, associated with poorer patient prognosis. These results suggest that FPR2 can be high-jacked by colon cancer cells for their growth advantage, thus becoming a potential target for therapeutic development.
机译:G蛋白偶联的趋化因子受体甲酰肽受体2(人中为FPR2,小鼠中为Fpr2)由小鼠结肠上皮细胞表达,在介导粘膜稳态和炎症反应中起关键作用。但是,FPR2在人类结肠中的生物学作用尚不清楚。我们的研究表明,相当数量的人类结肠癌细胞系表达FPR2,其配体可促进细胞迁移和增殖。与表达较低水平的FPR2的细胞系相比,表达高水平的FPR2的人结肠癌细胞系在免疫受损的小鼠中还形成了更快生长的肿瘤。从高表达FPR2的结肠癌细胞系中敲除FPR2可降低其致瘤性。在临床上,FPR2在进行性结肠癌中表达更高,与患者预后较差有关。这些结果表明,FPR2可以因其生长优势而受到结肠癌细胞的劫持,从而成为治疗发展的潜在靶标。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号